ISSN 2326-7267
International Journal of Pharmacy and Pharmacology ISSN: 2326-7267 Vol. 9 (6), pp. 001-010, June, 2020. © International Scholars Journals
Full Length Research Paper
Impact of a community pharmacist-based diabetes management program on clinical outcomes measures
Lee Y.L1, Rosnani H2, Syed A.S.S3, Syed W.G4*, Yelly O.S5,6, Usman H.U7
1Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur. Alcare Pharmacy Sdn Bhd, 107, Jalan Temenggong, 75000 Malacca, 2 Department of Pharmacy, Faculty of Allied Health Sciences, Kuala Lumpur Campus, 3 Dean, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), 4 Lecturer, Discipline of Clinical Pharmacy, USM, 5 Faculty of Pharmacy, Andalas University, Padang 25163, Indonesia, 6 Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia, 7 Master Student, School of Dental Sciences, Universiti Sains Malaysia.
Accepted 22 March 2020
Abstract
This is a prospective pre-post study which was carried out to assess the impact of a community pharmacist-based diabetes management program on clinical outcomes measures. Forty seven outpatients from the Government polyclinic were initially enrolled for this study but only 30 stayed on till the end of the program which was for duration of 3 months. Subjects were followed-up on 4 visits, whereby the community pharmacist provided a structured, standardized diabetes education program which involved counseling and education. Each session lasted about 1 hour on a one to one basis. Lifestyle behaviours such as physical activities, smoking and alcohol consumption were also evaluated. Compliance, awareness and also their knowledge on diabetes were assessed. A Likert-type patient satisfaction survey was also conducted. At the end of the study, HbA1c was significantly reduced by 1.2% (p< 0.001), post-prandial 2 hours blood glucose reduced by 3.34mmol/l (p< 0.001), total cholesterol decreased by 0.37mmol/l (p<0.016), systolic blood pressure decreased by 9.1mmHg (p< 0.001), diastolic blood pressure decreased by 4.8mmHg (p<0.001). Weight, BMI and waist circumference did not change significantly. There was a significant improvement in the compliance score and the patients were satisfied with the outcome of the program which showed better control of their diabetes. In conclusion, the community pharmacist has made an impact on the clinical outcome measures of the diabetic patient who participated in the program.
Keywords: Diabetes, Disease Management, Pharmaceutical Care, Community Pharmacy